Bethea ED, Chen Q, Hur C, et al. Cost-effectiveness of Treating Acute versus Chronic Hepatitis C Infection Using Direct-Acting Antivirals. AASLD 2017, abstract 24.
Stoppen met nucleos(t)ide-analogen bij HBeAg-negatieve chronische hepatitis B?
aug 2023 | Hepatitis, Hepatologie